Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Financial Information

Financial InformationSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Here you will find a summary of Spectrum Pharmaceuticals, Inc.'s latest financial information.

Latest Earnings Release and 10-Q Date Filed Format Size  
Second Quarter Financial Results HTML file N/A  
Form 10-Q Aug 8, 2014 HTML file  PDF file   View XBRL 902.1 KB Add to Briefcase
Form 10-Q May 12, 2014 HTML file  PDF file   View XBRL 436.8 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
2013 Annual Report   PDF 2.3 MB Add to Briefcase
Form 10-K Mar 12, 2014 HTML file  PDF file   View XBRL 1.6 MB Add to Briefcase
Form 10-K/A Dec 6, 2013 HTML file  PDF file   View XBRL 1.5 MB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFA14A) Apr 29, 2014 HTML file  PDF file 157.3 KB Add to Briefcase
Proxy Statement Apr 29, 2014 HTML file  PDF file 799.8 KB Add to Briefcase
Proxy Statement (PRE 14A) Apr 11, 2014 HTML file  PDF file 659.1 KB Add to Briefcase

Add to Briefcase = add PDF file to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
8.11
Change:
+ 0.14
Day High:
8.12
Day Low:
7.96
Volume:
457,300
4:00 PM ET on Aug 29, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company